Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/CTRI/2020/08/027335
CTRI/2020/08/027335Not yet recruitingPhase 1/2

A Clinico-Anatomical Study of Pleeha in Pleehodara Roga W.S.R. to Therapeutic Effect of Sharpunkha Kshara

University College of Ayurveda1 site in 1 country30 target enrollmentStarted: October 16, 2020Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Phase 1/2
Status
Not yet recruiting
Sponsor
Enrollment
30
Locations
1
Primary Endpoint
Improvement in Subjective and Objective criteria.
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

It is a Randomized ParallelGroup Clinical Trial of 30 Patients Which are Divided in 3 Groups. Each GroupConsist of 10 Patients. First Group Will be treated with Medicine Prescribed inOPD. Second Group Will be treated with Medicines Provide in OPD/IPD +Sharpunkha Kshara.Third Group Will Be Treated with Only Sharpunkha Kshara

Study Design

Study Type
Interventional
Allocation
Computer generated randomization
Masking
Not Applicable

Eligibility Criteria

Ages
20.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • •Patients with the classical signs and symptoms of Pleehavridhi (splenomegaly).

Exclusion Criteria

  • •Patients with other Systemic Diseases like Diabetes Mellitus, Malignancy, CHD, etc.
  • •HbsAg and HIV Positive Patients.

Outcomes

Primary Outcomes

Improvement in Subjective and Objective criteria.

Time Frame: 2 Weeks

Secondary Outcomes

  • To find out the Efficay of Sharpunkha Kshara(1 month)

Investigators

Sponsor
University College of Ayurveda
Sponsor Class
Government medical college

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Study the Effect of Acupuncture on Migraine Patient Without Aura Via Functional Magnetic Resonance Imaging.Migraine Without Aura
NCT04636359Beijing University of Chinese Medicine30
Completed
Phase 2
Evaluation of Triphala and chlorhexidine mouthwash use in reducing tooth decay and gum problemsICD 10 - K05.1Chronic gingivitis
CTRI/2017/10/010155Dr Ketaki Bhor72
Completed
Phase 1
Study to Investigate Comparative Pharmacokinetics, Safety, Immunogenicity and Tolerability Between AVT80 and EntyvioHealthy Male and Female Subjects
NCT06732804Alvotech Swiss AG385
Completed
Phase 3
The Efficacy and Safety Study of Protoxin Versus Botox® in Subjects With Moderate to Severe Glabellar LinesGlabellar Frown Lines
NCT05364580Protox Inc.269
Completed
Phase 3
A Study on Efficacy, Safety and Immunogenicity of 9MW0311 in Postmenopausal Women With OsteoporosisPostmenopausal Women Osteoporosis
NCT06804590Mabwell (Shanghai) Bioscience Co., Ltd.280